Enterprise value to revenue forward of BrightSpring Health Services, Inc. - Tangible Equity – NASDAQ:BTSGU
The article focuses on the enterprise value to revenue forward of BrightSpring Health Services, Inc. (NASDAQ: BTSGU). It highlights the company's financial overview on TradingView, stating that the market for this stock is currently closed with no trades. The content briefly mentions the data providers for market and reference data.
Analysts Are Bullish on These Healthcare Stocks: BrightSpring Health Services, Inc. (BTSG), Relay Therapeutics (RLAY)
Analysts are showing bullish sentiment towards several healthcare stocks, including BrightSpring Health Services, Inc. (BTSG), Relay Therapeutics (RLAY), and Krystal Biotech (KRYS). TD Cowen analysts maintained Buy ratings for all three, with specific price targets and a "Strong Buy" consensus for each company based on TipRanks data. Goldman Sachs also initiated coverage on BrightSpring Health Services with a Buy rating.
BrightSpring Appoints AI Expert Nigam Shah to Board
BrightSpring Health Services, Inc. has expanded its board of directors with the appointment of Dr. Nigam H. Shah, a Stanford professor and healthcare data expert. Dr. Shah, known for his work in AI, data science, and clinical informatics, will also sit on the Board's Quality and Compliance Committee. This move aims to integrate deep AI and data expertise into BrightSpring's governance, reinforcing its strategy to leverage technology for improved patient outcomes and a stronger competitive position in healthcare.
BrightSpring (BTSG) director Nigam Shah granted 4,013 RSUs in 2026
BrightSpring Health Services director Nigam H. Shah was granted 4,013 Restricted Stock Units (RSUs) on June 11, 2026, as part of his compensation. These RSUs fully vest on the earlier of June 11, 2027, or the day before the company's 2027 annual meeting of stockholders, and each represents one share of common stock upon settlement. Following this grant, Shah directly holds 4,013 shares of BrightSpring common stock.
Stanford AI doctor Nigam Shah joins BrightSpring board, Quality Committee
BrightSpring Health Services (NASDAQ:BTSG) has appointed Dr. Nigam H. Shah, a Stanford professor and AI expert, to its Board of Directors and the Quality and Compliance Committee, effective June 11, 2026. Dr. Shah, known for his work in applying AI and data science to improve healthcare outcomes, brings extensive experience from Stanford Healthcare and various co-founded companies. His addition aims to leverage technology and artificial intelligence to drive better solutions for patients and address healthcare challenges.
BrightSpring Health Services appoints Stanford professor to board
BrightSpring Health Services has appointed Dr. Nigam H. Shah, a Stanford University professor specializing in biomedical data science and clinical AI, to its Board of Directors as a Class III member. Dr. Shah, who will also serve on the Quality and Compliance Committee, brings extensive experience in applying technology and data insights to healthcare. BrightSpring, a provider of home and community-based health services, has shown significant growth with shares surging 192% over the past year.
BrightSpring (BTSG) insider exercises options and sells 260,000 shares
BrightSpring Health Services director Jon B. Rousseau exercised stock options for 260,000 shares at $6.37 per share and subsequently sold the same number of shares at $58.75 per share. These transactions, which included sales by The Margaret Rousseau Children Trust under a registered public offering, resulted in a net share sale of 260,000. Following these actions, Rousseau still holds significant direct and indirect interests in the company, including 1,194,503 common shares and options for 377,602 underlying shares.
BrightSpring (NASDAQ: BTSG) executive exercises 35K options, sells 35K shares in offering
Lisa A. Nalley, an executive at BrightSpring Health Services, Inc. (NASDAQ: BTSG), exercised 35,000 stock options at $6.37 per share and subsequently sold 35,000 shares in a registered public offering at $58.75 per share on June 5, 2026. This transaction allowed Nalley to convert her option-based compensation into cash while retaining a significant equity stake of 131,948 common shares and 41,909 vested stock options. The activity is described as routine liquidity management rather than a change in investment thesis.
KKR-affiliated entities sell $857.5m in BrightSpring Health stock
KKR-affiliated entities, including founding partners Henry R. Kravis and George R. Roberts, have sold approximately $857.5 million worth of BrightSpring Health Services (NASDAQ:BTSG) common stock. This significant sale follows a 144% surge in BrightSpring shares over the past year and an InvestingPro analysis suggesting the stock is overvalued. Despite analyst upgrades from Morgan Stanley and BMO Capital, the stock saw a decline after the announcement of a secondary offering.
Brightspring Health Services stock hits all-time high at 54.69 USD
Brightspring Health Services (BTSG) stock has reached an all-time high of $54.69, marking a 137.51% increase over the past year. This surge follows strong investor confidence, a market capitalization of $10.86 billion, and impressive revenue growth of 28% over the last twelve months. The company also reported first-quarter 2026 earnings that significantly surpassed expectations, leading analysts to raise price targets.
BrightSpring Health Services (BTSG) Is Up 5.6% After Raising Revenue Guidance On Specialty Pharmacy Strength - Has The Bull Case Changed?
BrightSpring Health Services (BTSG) reported strong first-quarter results, exceeding expectations and raising full-year revenue and EBITDA guidance due to specialty pharmacy growth and recent home health acquisitions. The company's investment narrative centers on scaling its integrated home and community care platform profitably while managing financial risks. Despite the positive outlook and a new buyback authorization, investors are cautioned to consider potential challenges like rising wage pressure and funding concentration.
BrightSpring Health Services (BTSG) Profitability Turnaround Tests Bullish Growth Narrative
BrightSpring Health Services (BTSG) reported strong Q4 2025 revenues of US$3.6 billion and a positive EPS of US$0.24, marking a significant profitability turnaround from previous losses. While analysts are optimistic about future growth in specialty pharmacy and rare drug markets, the company's high P/E ratio of 101x and significant debt, with weak interest coverage, raise concerns for cautious investors. The article highlights a large discount to DCF fair value but warns that financial leverage and thin profit margins may constrain equity holder benefits.
Brightspring Health earnings up next: Can specialty sustain?
Brightspring Health Services Inc. is set to report first-quarter earnings, with analysts expecting a sequential decline in EPS. Investors will closely watch specialty pharmacy momentum, progress toward organic EBITDA growth targets, and margin expansion within Provider Services. The earnings report will determine if the company can sustain its recent rally and bullish narrative.
BrightSpring before Q1 earnings: Buy, sell or hold the stock now?
This article evaluates BrightSpring's stock performance ahead of its Q1 earnings report. It advises investors on whether to buy, sell, or hold the stock based on current trends and market predictions.
BrightSpring Health Services, Inc. (BTSG) Is Attractively Priced Despite Fast-paced Momentum
BrightSpring Health Services, Inc. (BTSG) is identified as an attractively priced stock, despite recently experiencing fast-paced momentum. The article highlights key factors to consider for potential investors, including valuation, growth expectations, and analyst revisions. It suggests that if the company can maintain its growth, the current price offers an appealing entry point.
Wells Fargo Maintains BrightSpring Health Services (BTSG) Overweight Recommendation
Wells Fargo has reiterated its Overweight rating for BrightSpring Health Services (BTSG). This indicates the firm's positive outlook on the company's stock performance. The maintenance of this rating suggests continued confidence in BrightSpring Health Services by Wells Fargo.
BrightSpring Health Services (BTSG) price target increased by 18.29% to 53.65
The price target for BrightSpring Health Services (BTSG) has been increased by 18.29% to $53.65. This adjustment reflects an updated valuation for the company's stock.
Recent price trend in BrightSpring Health Services, Inc. (BTSG) is your friend, here's why
The article discusses how the recent price trend of BrightSpring Health Services, Inc. (BTSG) indicates that the stock is a buy. It highlights that the 200-day simple moving average (SMA) suggests strong upside potential, while the more sensitive 50-day SMA is showing early signs of a bullish cross. Investors are advised to consider the stock based on these technical indicators.
BrightSpring Health Services (BTSG) price target increased by 18.29% to 53.65
BrightSpring Health Services (BTSG) recently saw its price target raised by 18.29%, bringing it to $53.65. This adjustment reflects an updated outlook from analysts regarding the company's valuation.
Does BrightSpring (BTSG) Have the Leadership and Strategy to Deliver Its Organic EBITDA Ambitions?
BrightSpring Health Services confirmed the resignation of Robert Barnes, President of ResCare Community Living, unrelated to operations. This comes as BrightSpring outlined ambitious long-term organic EBITDA growth targets (15-20% through 2028) at its investor day, driven by Infusion and Home & Community growth, AI efficiencies, and M&A. Investors should consider these growth prospects against the company's high leverage and sensitivity to interest costs.
BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026
BrightSpring Health Services, Inc. (NASDAQ: BTSG) announced it will release its first quarter 2026 financial results on Friday, May 1, 2026. The company will host an earnings conference call at 8:30 a.m. ET on the same day, with registration and webcast access available through its investor relations website. BrightSpring provides home- and community-based health solutions, serving over 450,000 customers daily across all 50 states.
Leerink Maintains Outperform on BrightSpring Health Services (BTSG) March 2026
Leerink Partners has maintained an "Outperform" rating on BrightSpring Health Services (BTSG) following the company's Investor Day on March 18, 2026. This reaffirmation signals continued analyst confidence from the healthcare-focused firm, though no new public price target was issued. Despite the maintained positive rating, BTSG shares experienced a slight short-term decline.
Did BrightSpring’s Push into Acquisitions and High-Population CON States Just Shift Its (BTSG) Investment Narrative?
BrightSpring Health Services (BTSG) is actively pursuing acquisitions and expansions in high-population, certificate-of-need states, aiming for geographic density and capital-efficient growth. While this strategy could reshape its investment narrative, promising substantial revenue and earnings growth, it also introduces risks such as higher debt, integration challenges, and reimbursement dependence. Investors are urged to consider these factors alongside optimistic analyst forecasts suggesting a significant upside to its current price.
5 Relative Price Strength Picks for Choppy Market Phases
In a volatile market influenced by global events and mixed economic signals, identifying stocks with strong relative price strength is crucial. This article highlights five companies – The Allstate Corporation (ALL), Five Below (FIVE), Archrock (AROC), BrightSpring Health Services (BTSG), and The Beachbody Company (BODI) – that exhibit strong fundamentals and have outperformed the S&P 500, making them potentially lucrative investments during choppy market phases. The selection process involved specific screening parameters like Zacks Rank #1, positive estimate revisions, current price above $5, high trading volume, and favorable VGM scores.
A Look At BrightSpring Health Services (BTSG) Valuation After Analyst Upgrades And Specialty Pharmacy Growth Plans
BrightSpring Health Services (BTSG) has seen increased investor attention following its presentation at the Leerink Global Healthcare Conference, where it discussed efficiency efforts and specialty pharmacy growth. Analysts have upgraded the stock, which is currently trading at a 31% discount to their target despite a 124% increase over the past year. While one narrative suggests it is 23.4% undervalued with a fair value of $51.00, another view highlights its high P/E ratio of 74.9x, indicating potential overvaluation on current earnings.
Lisa Nalley Sells 30,000 Shares of BrightSpring Health Services (NASDAQ:BTSG) Stock
Lisa Nalley, an insider at BrightSpring Health Services (NASDAQ:BTSG), recently sold 30,000 shares of the company's stock for $1,234,500, reducing her stake by over 21%. This sale comes amidst mixed fundamentals for the company, including strong revenue growth but an EPS miss, and the stock trading at a high P/E ratio near its 52-week high. Despite the insider sale, institutional investors have significantly increased their holdings, and analysts generally maintain a positive outlook with an average target price of $44.08.
Jon Rousseau Sells 220,000 Shares of BrightSpring Health Services (NASDAQ:BTSG) Stock
Jon Rousseau, an insider at BrightSpring Health Services (NASDAQ:BTSG), sold 220,000 shares of the company's stock for approximately $9.05 million. This transaction reduced his stake by 17.69%. Despite mixed Q4 fundamentals, with revenue up but EPS missing estimates and a high P/E ratio, the company has received "Buy" ratings from analysts and significant institutional investment, leading to a consensus target price of $44.08.
Segall Bryant & Hamill LLC Acquires 42,840 Shares of BrightSpring Health Services, Inc. $BTSG
Segall Bryant & Hamill LLC recently increased its stake in BrightSpring Health Services (NASDAQ:BTSG) by 51.7%, purchasing an additional 42,840 shares to now own 125,768 shares valued at approximately $3.72 million. Despite a slight EPS miss last quarter, BrightSpring exceeded revenue expectations and analysts maintain a "Buy" rating with an average target price around $44.08, following several increased price targets from firms like Wells Fargo and Mizuho. The company's stock has seen positive sentiment from analysts and upward earnings estimate revisions.
Latham Advises on BrightSpring’s Secondary Offering of Common Stock and Concurrent Share Repurchase
Latham & Watkins LLP advised on BrightSpring Health Services, Inc.'s secondary offering of 20,000,000 shares of common stock at US$41.15 per share by certain selling stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P. BrightSpring itself is not selling shares in this offering, and all proceeds will go to the selling stockholders. The offering is expected to close on March 4, 2026, with Latham's Capital Markets team, led by partners Marc Jaffe, Ian Schuman, and Kaj Nielsen, representing the underwriter.
Surging Earnings Estimates Signal Upside for BrightSpring Health Services, Inc. (BTSG) Stock
BrightSpring Health Services, Inc. (BTSG) is showing significant upside potential due to remarkably improving earnings outlooks and rising analyst optimism. The company has a Zacks Rank #1 (Strong Buy) indicating expected outperformance, with strong upward revisions in consensus estimates for both the upcoming quarter and the full year. This positive trend, correlated with near-term stock price movements, suggests further gains for investors.
BrightSpring Health Services (NASDAQ:BTSG) Upgraded by Zacks Research to "Strong-Buy" Rating
Zacks Research has upgraded BrightSpring Health Services (NASDAQ:BTSG) from a "hold" to a "strong-buy" rating, joining other analysts who have issued positive ratings and price target increases, leading to a consensus "Buy" rating and a target of $44.08. The company reported $3.55 billion in revenue (up 29.3% year-over-year) but narrowly missed EPS estimates at $0.33. Institutional investors are also showing increased interest in BTSG, with several firms raising or establishing new positions.
Royce & Associates LP Buys 44,505 Shares of BrightSpring Health Services, Inc. $BTSG
Royce & Associates LP significantly increased its stake in BrightSpring Health Services (NASDAQ:BTSG) by 32.2%, acquiring an additional 44,505 shares, bringing their total to 182,538 shares worth approximately $5.4 million. This move comes despite a recent large secondary offering by existing shareholders, which will increase the stock's float. The article also highlights strong bullish sentiment from Wall Street analysts, with several firms raising price targets and a consensus "Moderate Buy" rating, following BrightSpring's 29.3% year-over-year revenue growth.
Citigroup Inc. Buys 56,507 Shares of BrightSpring Health Services, Inc. $BTSG
Citigroup Inc. increased its stake in BrightSpring Health Services (NASDAQ:BTSG) by 42.2% in the third quarter, acquiring an additional 56,507 shares to own a total of 190,357 shares valued at approximately $5.63 million. This comes amidst a secondary offering of 20,000,000 shares by selling stockholders, which likely put downward pressure on the stock, despite concurrent share repurchase plans by management. Analysts largely maintain a "Moderate Buy" rating with an average price target of $42.85, as the stock trades around $40.65.
BrightSpring (NASDAQ: BTSG) resale: 20M shares, $822.7M public offering
BrightSpring Health Services (NASDAQ: BTSG) has filed a resale prospectus for 20 million shares of common stock by selling stockholders, with an offering price of $41.15 per share, totaling approximately $819.22 million in proceeds to the sellers. The company itself will not receive proceeds from this resale, except from cash exercises of management stock options. Concurrently, BrightSpring intends to repurchase and cancel 1,464,807 shares from the underwriter, contingent on the offering's closing, funding this buyback from cash on hand.
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
BrightSpring Health Services, Inc. announced the pricing of a secondary offering of 20,000,000 shares of common stock by certain stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P., at $41.15 per share. The company itself is not selling shares but will concurrently repurchase 1,464,807 shares from the underwriter. The offering is expected to close on March 4, 2026, with Goldman Sachs & Co. LLC acting as the sole book-running manager.
BrightSpring Health Services, Inc. $BTSG Shares Sold by Quantbot Technologies LP
Quantbot Technologies LP significantly reduced its stake in BrightSpring Health Services (NASDAQ:BTSG) by 53.8% in Q3, selling 114,883 shares and now holding 98,474 shares valued at $2.91 million. Despite this, BrightSpring reported strong revenue growth of 29.3% year-over-year, beating analyst estimates, although its EPS slightly missed projections. The company maintains a "Moderate Buy" consensus rating with an average analyst price target of $42.46, indicating a positive outlook despite its high P/E ratio.
TD Asset Management Inc Increases Holdings in BrightSpring Health Services, Inc. $BTSG
TD Asset Management Inc. significantly increased its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 18.3% during the third quarter, bringing its total ownership to 474,988 shares valued at approximately $14.04 million. This move follows BrightSpring's strong Q4 revenue beat, although EPS slightly missed expectations. The company currently holds a "Moderate Buy" consensus rating from analysts, with an average target price of $41.33.
Vanguard Group Inc. Acquires 576,906 Shares of BrightSpring Health Services, Inc. $BTSG
Vanguard Group Inc. increased its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 6.4% in the third quarter, acquiring an additional 576,906 shares to own a total of 9,604,703 shares. The article details other institutional investments in BrightSpring, highlights recent financial performance including Q4 revenue exceeding expectations, and provides analyst ratings. Despite a slight Q4 EPS miss, the company's revenue growth and 2026 guidance show positive sentiment.
BrightSpring Health Services (BTSG) EPS Jump In Q4 2025 Tests Bullish Profitability Narrative
BrightSpring Health Services (BTSG) reported a significant jump in Q4 2025 earnings per share (EPS) to US$0.24, with full-year net income of US$106.3 million on US$12.9 billion in revenue, marking a swing from a prior year loss. While this signals improving profitability, aligning with narratives of specialty pharmacy growth and efficiency, the company's high P/E ratio of 80.5x, compared to peers and the sector, and weak interest coverage, raise valuation and risk concerns for investors. The article highlights both bullish arguments for scaling profits and bearish concerns regarding current valuation and financial pressures.
BrightSpring Health Services Q4 FY25 earnings jump on strong revenue growth
BrightSpring Health Services (NASDAQ: BTSG) reported a significant increase in revenue and net income for Q4 FY25, with net revenue rising 29.3% to $3,551 million and net income climbing to $77.1 million. The company also saw adjusted EBITDA increase by 40.7% and acquired 107 home health and hospice branches. For fiscal 2026, management projects revenues between $14,450 million and $15,000 million.
BrightSpring Health Services Inc (BTSG) Shares Up 10.98% on Feb 27
BrightSpring Health Services Inc (BTSG) shares rose 10.98% on February 27, settling at $44.53. This places the stock near its 52-week high, with a trading volume of 961,805 shares. Wall Street analysts predict an average target price of $44.47, indicating an "Outperform" status from brokerage firms.
BrightSpring (NASDAQ: BTSG) swings to 2025 profit with growth
BrightSpring Health Services (NASDAQ: BTSG) reported a significant financial turnaround in 2025, swinging to a net profit of $189.1 million from a $20.5 million loss in 2024. The company's total revenues increased to $12.91 billion, and Adjusted EBITDA grew to $617.6 million. BrightSpring also provided optimistic 2026 guidance, expecting continued revenue and Adjusted EBITDA growth.
BrightSpring Health Services, Inc. SEC 10-K Report
BrightSpring Health Services, Inc. announced significant financial growth in its 2025 10-K report, with total revenues of $12.91 billion and a net income of $104.8 million, marking a strong turnaround in profitability. The company is strategically divesting its Community Living business for $835 million to focus on home-based healthcare services and expanding its presence through acquisitions and improved integrated care strategies. Despite challenges like intense competition and regulatory changes, BrightSpring aims for continued growth in value-based care and operational excellence.
UnitedHealth closes $239M sale of 107 home care locations
UnitedHealth has finalized the sale of 107 home care locations for $239 million, as reported by Diane Eastabrook on February 27, 2026. This divestiture is part of a larger transaction involving BrightSpring Health Services. The article, concise in nature, primarily announces the completion of this significant financial deal in the healthcare sector.
HighTower Advisors LLC Invests $3.63 Million in BrightSpring Health Services, Inc. $BTSG
HighTower Advisors LLC has initiated a new position in BrightSpring Health Services, Inc. (NASDAQ: BTSG), purchasing 122,625 shares valued at approximately $3.63 million. This investment highlights increasing institutional interest, with other major firms like Invesco and AllianceBernstein also significantly expanding their holdings. Analyst sentiment for BrightSpring Health Services is largely positive, with a "Moderate Buy" consensus rating and several recent price target increases.
TD Cowen is Bullish on BrightSpring Health Services, Inc. (BTSG)
TD Cowen has reiterated its bullish stance on BrightSpring Health Services, Inc. (BTSG), upgrading its price objective to $46 and maintaining a Buy rating, citing strong specialty generics trends. Other firms, including BMO Capital and BTIG, have also increased their price targets for BTSG, highlighting the company's competitive advantage, pharmaceutical ties, and consistent operational performance. The stock's recent performance is largely attributed to accelerated growth within its specialty division.
TD Cowen is Bullish on BrightSpring Health Services, Inc. (BTSG)
TD Cowen has upgraded its price objective for BrightSpring Health Services, Inc. (BTSG) to $46 from $42, maintaining a Buy rating due to strong specialty generics trends. BMO Capital and BTIG have also raised their price targets for BTSG, citing competitive positioning, solid pharmaceutical ties, and consistent performance. The company, which provides healthcare and pharmaceutical solutions, has shown impressive stock performance driven by growth in its specialty division.
Persistent Asset Partners Ltd Takes $2.25 Million Position in BrightSpring Health Services, Inc. $BTSG
Persistent Asset Partners Ltd has acquired a new position in BrightSpring Health Services, Inc. (NASDAQ:BTSG) during the third quarter, purchasing 76,060 shares valued at approximately $2.25 million. This investment now represents 1.5% of Persistent Asset Partners Ltd's portfolio, making it their 15th largest holding. Several other institutional investors have also adjusted their stakes in BrightSpring Health Services, and Wall Street analysts currently rate the stock as a "Moderate Buy" with an average target price of $41.33.
Brightspring Health Services stock hits all-time high at 41.4 USD By Investing.com
Brightspring Health Services (BTSG) stock has reached an all-time high of $41.40, marking a significant 95.93% increase over the past year. This surge is attributed to strong market performance, strategic company initiatives, and positive analyst sentiment, with several firms raising price targets and maintaining "Buy" or "Overweight" ratings due to the company's robust growth in its specialty business and efficient operations.
BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026
BrightSpring Health Services, Inc. (NASDAQ: BTSG) announced it will host an Investor Day on Tuesday, March 17, 2026, starting at 8:30 a.m. ET. The event will feature presentations and Q&A sessions with the company's leadership team. BrightSpring provides home- and community-based health solutions, serving over 450,000 customers daily across all 50 states through pharmacy, home health, primary care, rehabilitation, and behavioral health services.
